Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-low contrast dose in CTA
NCT02669784Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Feb 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of iohexol in aortic aneurysm and Aortic and Arterial Anomalies (AAOCA) (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Ascending Sinotubular Junction Measurement at 30 days, Descending Thoracic Aorta Measurement at 30 days and 6 more. Started Feb 2016; status: completed.
02
Drugs
iohexol
03
Conditions
aortic aneurysmAortic and Arterial Anomalies (AAOCA)
Beyond the preview
Go deeper on NCT02669784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669784.